The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Survival in glioblastoma: a review on the impact of treatment modalities
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Ostrom, Q. T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz-Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 11,994
Stupp, R., Hegi, M. E., Mason, W. P., van den Bent, M. J., Taphoorn, M. J., Janzer, R. C., Ludwin, S. K., Allgeier, A., Fisher, B., Belanger, K., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70025-7 · Cited by 7,668
Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575 · cited 2×
“Based on genetic alterations and expression profiles and according to The Cancer Genome Atlas, GBM is classified into four subtypes: classical, mesenchymal, proneural and neural [16].”
BackgroundMethodMGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857 · cited 1×
“Interestingly, IDH1 mutations occur in a very large proportion of younger patients and in more than 80 % of secondary GBM, compared to less than 5 % of primary GBM [14].”
BackgroundImmunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
Grauer, O. M., Wesseling, P., & Adema, G. J. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00315.x · Cited by 4,007
Wen, P. Y., & Kesari, S. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0708126 · Cited by 3,511
Stummer, W., Pichlmeier, U., Meinel, T., Wiestler, O. D., Zanella, F., & Reulen, H.-J. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70665-9 · Cited by 3,423 · cited 1×
“Data from multivariate analysis show that extensive resections provide at least modest gains in overall survival [19] and progression-free survival [28].”
MethodPhillips, H. S., Kharbanda, S., Chen, R., Forrest, W. F., Soriano, R. H., Wu, T. D., Misra, A., Nigro, J. M., Colman, H., Soroceanu, L., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.02.019 · Cited by 3,143
Lacroix, M., Abi-Said, D., Fourney, D. R., Gokaslan, Z. L., Shi, W., DeMonte, F., Lang, F. F., McCutcheon, I. E., Hassenbusch, S. J., Holland, E., et al. (2001) · Journal of Neurosurgery · doi:10.3171/jns.2001.95.2.0190 · Cited by 3,091
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
Friedman, H. S., Prados, M. D., Wen, P. Y., Mikkelsen, T., Schiff, D., Abrey, L. E., Yung, W. K. A., Paleologos, N., Nicholas, M. K., Jensen, R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.8721 · Cited by 2,466
Glioma Groups Based on 1p/19q,IDH, and TERT Promoter Mutations in Tumors
Eckel-Passow, J. E., Lachance, D. H., Molinaro, A. M., Walsh, K. M., Decker, P. A., Sicotte, H., Pekmezci, M., Rice, T., Kosel, M. L., Smirnov, I. V., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1407279 · Cited by 1,982
Ostrom, Q. T., Gittleman, H., Liao, P., Rouse, C., Chen, Y., Dowling, J., Wolinsky, Y., Kruchko, C., & Barnholtz-Sloan, J. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou223 · Cited by 1,718
An extent of resection threshold for newly diagnosed glioblastomas: Clinical article
Sanai, N., Polley, M.-Y., McDermott, M. W., Parsa, A. T., & Berger, M. S. (2011) · Journal of Neurosurgery · doi:10.3171/2011.2.jns10998 · Cited by 1,646
Walker, M. D., Green, S. B., Byar, D. P., Alexander, E., Batzdorf, U., Brooks, W. H., Hunt, W. E., MacCarty, C. S., Mahaley, M. S., Mealey, J., et al. (1980) · New England Journal of Medicine · doi:10.1056/nejm198012043032303 · Cited by 1,611
Kreisl, T. N., Kim, L., Moore, K., Duic, P., Royce, C., Stroud, I., Garren, N., Mackey, M., Butman, J. A., Camphausen, K., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.3055 · Cited by 1,577
Brem, H., Piantadosi, S., Burger, P. C., Walker, M., Selker, R., Vick, N. A., Black, K., Sisti, M., Brem, S., Mohr, G., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90755-6 · Cited by 1,389
Ohgaki, H., & Kleihues, P. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.6.479 · Cited by 1,381
The Definition of Primary and Secondary Glioblastoma
Ohgaki, H., & Kleihues, P. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3002 · Cited by 1,132
Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
Sanson, M., Marie, Y., Paris, S., Idbaih, A., Laffaire, J., Ducray, F., El Hallani, S., Boisselier, B., Mokhtari, K., Hoang-Xuan, K., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.9832 · Cited by 1,008
Long-term survival with glioblastoma multiforme
Krex, D., Klink, B., Hartmann, C., von Deimling, A., Pietsch, T., Simon, M., Sabel, M., Steinbach, J. P., Heese, O., Reifenberger, G., et al. (2007) · Brain · doi:10.1093/brain/awm204 · Cited by 887
Stupp, R., Wong, E. T., Kanner, A. A., Steinberg, D., Engelhard, H., Heidecke, V., Kirson, E. D., Taillibert, S., Liebermann, F., Dbalý, V., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.04.011 · Cited by 862
Epidemiology of primary brain tumors: Current concepts and review of the literature
Wrensch, M., Minn, Y., Chew, T., Bondy, M., & Berger, M. S. (2002) · Neuro-Oncology · doi:10.1093/neuonc/4.4.278 · Cited by 837
Senft, C., Bink, A., Franz, K., Vatter, H., Gasser, T., & Seifert, V. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70196-6 · Cited by 826
Hegi, M. E., Liu, L., Herman, J. G., Stupp, R., Wick, W., Weller, M., Mehta, M. P., & Gilbert, M. R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.5964 · Cited by 812
Radiotherapy for Glioblastoma in the Elderly
Keime-Guibert, F., Chinot, O., Taillandier, L., Cartalat-Carel, S., Frenay, M., Kantor, G., Guillamo, J.-S., Jadaud, E., Colin, P., Bondiau, P.-Y., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065901 · Cited by 792
Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma
Wallner, K. E., Galicich, J. H., Krol, G., Arbit, E., & Malkin, M. G. (1989) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(89)90941-3 · Cited by 782
IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas
Nobusawa, S., Watanabe, T., Kleihues, P., & Ohgaki, H. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0715 · Cited by 711
Laws, E. R., Parney, I. F., Huang, W., Anderson, F., Morris, A. M., Asher, A., Lillehei, K. O., Bernstein, M., Brem, H., Sloan, A., et al. (2003) · Journal of Neurosurgery · doi:10.3171/jns.2003.99.3.0467 · Cited by 670
Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.
Shinojima, N., Tada, K., Shiraishi, S., Kamiryo, T., Kochi, M., Nakamura, H., Makino, K., Saya, H., Hirano, H., Kuratsu, J., et al. (2003) · PubMed · Cited by 663
Souhami, L., Seiferheld, W., Brachman, D., Podgorsak, E. B., Werner-Wasik, M., Lustig, R., Schultz, C. J., Sause, W., Okunieff, P., Buckner, J., et al. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.04.011 · Cited by 562
Prognostic factors for survival of patients with glioblastoma: Recursive partitioning analysis
Lamborn, K. R., Chang, S. M., & Prados, M. D. (2004) · Neuro-Oncology · doi:10.1215/s1152851703000620 · Cited by 546
Heimberger, A. B., Hlatky, R., Suki, D., Yang, D., Weinberg, J., Gilbert, M., Sawaya, R., & Aldape, K. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1737 · Cited by 516
Chaichana, K. L., Jusue-Torres, I., Navarro-Ramirez, R., Raza, S. M., Pascual-Gallego, M., Ibrahim, A., Hernandez-Hermann, M., Gomez, L., Ye, X., Weingart, J. D., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/not137 · Cited by 505
Davis, F. G., Freels, S., Grutsch, J., Barlas, S., & Brem, S. (1998) · Journal of Neurosurgery · doi:10.3171/jns.1998.88.1.0001 · Cited by 482
Grabowski, M. M., Recinos, P. F., Nowacki, A. S., Schroeder, J. L., Angelov, L., Barnett, G. H., & Vogelbaum, M. A. (2014) · Journal of Neurosurgery · doi:10.3171/2014.7.jns132449 · Cited by 435
Impact of extent of resection for recurrent glioblastoma on overall survival: Clinical article
Bloch, O., Han, S. J., Cha, S., Sun, M. Z., Aghi, M. K., McDermott, M. W., Berger, M. S., & Parsa, A. T. (2012) · Journal of Neurosurgery · doi:10.3171/2012.9.jns12504 · Cited by 432
Survival and Failure Patterns of High-Grade Gliomas After Three-Dimensional Conformal Radiotherapy
Chan, J. L., Lee, S. W., Fraass, B. A., Normolle, D. P., Greenberg, H. S., Junck, L., Gebarski, S. S., & Sandler, H. M. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1635 · Cited by 420
Intraoperative MRI-guided resection of glioblastoma multiforme: a systematic review
Kubben, P. L., ter Meulen, K. J., Schijns, O. E., ter Laak-Poort, M. P., van Overbeeke, J. J., & Santbrink, H. V. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70130-9 · Cited by 408
Debulking or biopsy of malignant glioma in elderly people – a randomised study
Vuorinen, V., Hinkka, S., Färkkilä, M., & Jääskeläinen, J. (2003) · Acta Neurochirurgica · doi:10.1007/s00701-002-1030-6 · Cited by 370
Emerging treatment strategies for glioblastoma multiforme
Carlsson, S. K., Brothers, S. P., & Wahlestedt, C. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201302627 · Cited by 365
Glioblastoma multiforme: State of the art and future therapeutics
Harter, D., Wilson, T., & Karajannis, M. (2014) · Surgical Neurology International · doi:10.4103/2152-7806.132138 · Cited by 327
Orringer, D., Lau, D., Khatri, S., Zamora-Berridi, G. J., Zhang, K., Wu, C., Chaudhary, N., & Sagher, O. (2012) · Journal of Neurosurgery · doi:10.3171/2012.8.jns12234 · Cited by 317
Current trends in the surgical management and treatment of adult glioblastoma.
Young, R. M., Jamshidi, A. M., Davis, G., & Sherman, J. H. (2015) · PubMed · doi:10.3978/j.issn.2305-5839.2015.05.10 · Cited by 308
Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma
Iwamoto, F. M., Abrey, L. E., Beal, K., Gutin, P. H., Rosenblum, M. K., Reuter, V. E., DeAngelis, L. M., & Lassman, A. B. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bc0184 · Cited by 305
Athanassiou, H., Synodinou, M., Maragoudakis, E., Paraskevaidis, M., Verigos, C., Misailidou, D., Antonadou, D., Saris, G., Beroukas, K., & Karageorgis, P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.331 · Cited by 272
Oppenlander, M. E., Wolf, A. B., Snyder, L. A., Bina, R., Wilson, J. R., Coons, S. W., Ashby, L. S., Brachman, D., Nakaji, P., Porter, R. W., et al. (2014) · Journal of Neurosurgery · doi:10.3171/2013.12.jns13184 · Cited by 266
Selker, R. G., Shapiro, W. R., Burger, P., Blackwood, M. S., Deutsch, M., Arena, V. C., Van Gilder, J. C., Wu, J., Malkin, M. G., Mealey, J., et al. (2002) · Neurosurgery · doi:10.1097/00006123-200208000-00009 · Cited by 260
Fitzek, M. M., Thornton, A. F., Rabinov, J. D., Lev, M. H., Pardo, F. S., Munzenrider, J. E., Okunieff, P., Bussière, M., Braun, I., Hochberg, F. H., et al. (1999) · Journal of Neurosurgery · doi:10.3171/jns.1999.91.2.0251 · Cited by 256
Predictive impact of MGMT promoter methylation in glioblastoma of the elderly
Reifenberger, G., Hentschel, B., Felsberg, J., Schackert, G., Simon, M., Schnell, O., Westphal, M., Wick, W., Pietsch, T., Loeffler, M., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27385 · Cited by 252
Combined analysis of TERT , EGFR , and IDH status defines distinct prognostic glioblastoma classes
Labussière, M., Boisselier, B., Mokhtari, K., Di Stefano, A.-L., Rahimian, A., Rossetto, M., Ciccarino, P., Saulnier, O., Paterra, R., Marie, Y., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000814 · Cited by 218
Intraoperative stimulation techniques for functional pathway preservation and glioma resection
Sanai, N., & Berger, M. S. (2010) · Neurosurgical Focus · doi:10.3171/2009.12.focus09266 · Cited by 196
Long-Term Survival in Primary Glioblastoma With Versus Without Isocitrate Dehydrogenase Mutations
Hartmann, C., Hentschel, B., Simon, M., Westphal, M., Schackert, G., Tonn, J. C., Loeffler, M., Reifenberger, G., Pietsch, T., von Deimling, A., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0017 · Cited by 186
The role of Gliadel wafers in the treatment of high-grade gliomas
Bregy, A., Shah, A. H., Diaz, M. V., Pierce, H. E., Ames, P. L., Diaz, D., & Komotar, R. J. (2013) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2013.840090 · Cited by 176
Wong, E. T., Lok, E., Gautam, S., & Swanson, K. D. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.238 · Cited by 170
Farrell, C. J., & Plotkin, S. R. (2007) · Neurologic Clinics · doi:10.1016/j.ncl.2007.07.008 · Cited by 162
Survival after Stereotactic Biopsy of Malignant Gliomas
Coffey, R. J., Lunsford, L. D., & Taylor, F. H. (1988) · Neurosurgery · doi:10.1227/00006123-198803000-00003 · Cited by 154
Armstrong, T. S., Wefel, J. S., Wang, M., Gilbert, M. R., Won, M., Bottomley, A., Mendoza, T. R., Coens, C., Werner‐Wasik, M., Brachman, D. G., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.6067 · Cited by 153
Predicting the electric field distribution in the brain for the treatment of glioblastoma
Miranda, P. C., Mekonnen, A., Salvador, R., & Basser, P. J. (2014) · Physics in Medicine and Biology · doi:10.1088/0031-9155/59/15/4137 · Cited by 131 · cited 1×
“The electric field distribution in the brain seems to be highly non-uniform and depends on the tissue geometry and dielectric properties [76], which could explain variability in outcomes.”
BackgroundEljamel, S. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160510443 · Cited by 130
Pre-surgical planning and MR-tractography utility in brain tumour resection
Romano, A., D’Andrea, G., Minniti, G. C., Mastronardi, L., Ferrante, L., Fantozzi, L. M., & Bozzao, A. (2009) · European Radiology · doi:10.1007/s00330-009-1483-6 · Cited by 127
Gerber, D. E., Grossman, S. A., Zeltzman, M., Parisi, M., & Kleinberg, L. R. (2006) · Neuro-Oncology · doi:10.1215/15228517-2006-024 · Cited by 124
Survival after stereotactic biopsy of malignant gliomas
Coffey, R. J., Lunsford, L. D., & Taylor, F. H. (1988) · Neurosurgery · doi:10.1097/00006123-198803000-00003 · Cited by 124
Coburger, J., Hagel, V., Wirtz, C. R., & König, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131872 · Cited by 121
Gonzalez-Darder, J. M., González-López, P., Talamantes, F., Quilis-Quesada, V., Doñate, V. E. C., García-March, G., & Roldán, P. (2010) · Neurosurgical FOCUS · doi:10.3171/2009.11.focus09234 · Cited by 121
USEFULNESS OF INTRAOPERATIVE ULTRA LOW-FIELD MAGNETIC RESONANCE IMAGING IN GLIOMA SURGERY
Senft, C., Seifert, V., Hermann, E. J., Franz, K., & Gasser, T. (2008) · Operative Neurosurgery · doi:10.1227/01.neu.0000313624.77452.3c · Cited by 119
Lacouture, M. E., Davis, M. E., Elzinga, G., Butowski, N. A., Tran, D. D., Villano, J. L., DiMeglio, L., Davies, A. M., & Wong, E. T. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.03.011 · Cited by 112
Wangaryattawanich, P., Hatami, M., Wang, J., Thomas, G. A., Flanders, A. E., Kirby, J., Wintermark, M., Huang, E. S., Bakhtiari, A., Luedi, M. M., et al. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov117 · Cited by 101
Use of diffusion tensor imaging in glioma resection
Abdullah, K. G., Lubelski, D., Nucifora, P. G. P., & Brem, S. S. (2013) · Neurosurgical FOCUS · doi:10.3171/2013.1.focus12412 · Cited by 95
Application of nanoparticles on diagnosis and therapy in gliomas.
Hernández-Pedro, N. Y., Rangel-López, E., Magaña-Maldonado, R., de la Cruz, V. P., Santamaría del Angel, A., Pineda, B., & Sotelo, J. (2013) · BioMed Research International · doi:10.1155/2013/351031 · Cited by 84
Krieg, S. M., Sollmann, N., Obermueller, T., Sabih, J., Bulubas, L., Negwer, C., Moser, T., Droese, D., Boeckh‐Behrens, T., Ringel, F. A., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1258-1 · Cited by 83
Wu, J., Gong, X., Song, Y., Zhuang, D., Yao, C., Qiu, T.-M., Lu, J., Zhang, J., Zhu, W. P., Mao, Y. Q., et al. (2014) · Neurosurgery · doi:10.1227/neu.0000000000000372 · Cited by 66
Valle, R. D., Slof, J., Galván, J., Arza, C., Romariz, C., & Vidal, C. (2014) · Neurología (English Edition) · doi:10.1016/j.nrleng.2013.05.004 · Cited by 61
Valle, R. D., Slof, J., Galván, J., Arza, C., Romariz, C., & Vidal, C. (2013) · Neurología · doi:10.1016/j.nrl.2013.05.004 · Cited by 60
Management of Elderly Patients With Gliomas
Pérez‐Larraya, J. G., & Delattre, J. (2014) · The Oncologist · doi:10.1634/theoncologist.2014-0170 · Cited by 56
Cost-effectiveness of 5-aminolevulinic acid-induced fluorescence in malignant glioma surgery
Slof, J., Valle, R. D., & Galván, J. (2015) · Neurología (English Edition) · doi:10.1016/j.nrleng.2013.11.009 · Cited by 45
Slof, J., Valle, R. D., & Galván, J. (2014) · Neurología · doi:10.1016/j.nrl.2013.11.002 · Cited by 44
Poulsen, H. S., Urup, T. H., Michaelsen, S. R., Staberg, M., Lassen, U., & Villingshøj, M. (2014) · Cancer Management and Research · doi:10.2147/cmar.s39306 · Cited by 43
Rahmathulla, G., Hovey, Hashemi-Sardraei, & Ahluwalia, M. S. (2013) · OncoTargets and Therapy · doi:10.2147/ott.s38628 · Cited by 40
Turner, S., Gergel, T., Wu, H., Lacroix, M., & Toms, S. A. (2014) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-12-162 · Cited by 38
An Evidence-Based Review of Alternating Electric Fields Therapy for Malignant Gliomas
Wong, E. T., Lok, E., & Swanson, K. D. (2015) · Current Treatment Options in Oncology · doi:10.1007/s11864-015-0353-5 · Cited by 35
Wong, E. T., Lok, E., & Swanson, K. D. (2015) · Cancer Medicine · doi:10.1002/cam4.421 · Cited by 35
Omar, A. I. (2014) · Journal of Visualized Experiments · doi:10.3791/51638 · Cited by 18
Tetratricopeptide repeat domain 9A is an interacting protein for tropomyosin Tm5NM-1
Cao, S., Ho, G. H., & Lin, V. C. L. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-231 · Cited by 12
Cited by
Proteogenomic and metabolomic characterization of human glioblastoma
Wang, L.-B., Karpova, A., Gritsenko, M. A., Kyle, J. E., Cao, S., Li, Y., Rykunov, D., Colaprico, A., Rothstein, J. H., Hong, R., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.01.006 · Cited by 661
Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review
Singh, N., Miner, A., Hennis, L., & Mittal, S. (2020) · Cancer Drug Resistance · doi:10.20517/cdr.2020.79 · Cited by 398
TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM
Hung, A. L., Maxwell, R., Theodros, D., Belcaid, Z., Mathios, D., Luksik, A. S., Kim, E., Wu, A., Xia, Y., Garzon-Muvdi, T., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1466769 · Cited by 336
Durant, S. T., Zheng, L., Wang, Y., Chen, K., Zhang, L., Zhang, T., Yang, Z., Riches, L., Trinidad, A. G., Fok, J. H. L., et al. (2018) · Science Advances · doi:10.1126/sciadv.aat1719 · Cited by 309
Current status and future perspectives of sonodynamic therapy in glioma treatment.
Wang, X., Jia, Y., Wang, P., Liu, Q., & Zheng, H. (2017) · Ultrasonics Sonochemistry · doi:10.1016/j.ultsonch.2017.02.020 · Cited by 86
Metadata
- Authors
- Delgado-López, P. D., & Corrales-García, E. M.
- Venue
- Clinical and Translational Oncology
- Published
- 2016-03-10
- Volume
- 18
- Issue
- 11
- Pages
- 1062-1071
- ISSN
- 1699-048X (ISSN-L)
- 1699-3055
- OpenAlex
- W2296457333
- Cited by
- 659
- References
- 85
- FWCI
- 26.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.